发明公开
EP1673110A2 RADIOLABELED ANILINOQUINAZOLINES AND THEIR USE IN RADIOIMAGING AND RADIOTHERAPY
审中-公开
放射性注明苯胺基及其使用无线电操作和放射治疗
- 专利标题： RADIOLABELED ANILINOQUINAZOLINES AND THEIR USE IN RADIOIMAGING AND RADIOTHERAPY
- 专利标题（中）： 放射性注明苯胺基及其使用无线电操作和放射治疗
-
申请号： EP04770505.8申请日： 2004-09-12
-
公开(公告)号： EP1673110A2公开(公告)日： 2006-06-28
- 发明人: MISHANI, Eyal , LEVITZKI, Alexander , ORTU, Giuseppina , BEN-DAVID, Iris , ROZEN, Yulia
- 申请人： YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM , HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD.
- 申请人地址： Hi Tech Park, Edmond Safra Campus Givat Ram, Jerusalem 91390 IL
- 专利权人： YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM,HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD.
- 当前专利权人： YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM,HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD.
- 当前专利权人地址： Hi Tech Park, Edmond Safra Campus Givat Ram, Jerusalem 91390 IL
- 代理机构： Schmitz, Jean-Marie
- 优先权： US659747 20030911
- 国际公布： WO2005023315 20050317
- 主分类号： A61K51/04
- IPC分类号： A61K51/04
摘要：
Radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors and their use as biomarkers for medicinal radioimaging such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and as radiopharmaceuticals for radiotherapy are disclosed.
信息查询
